baber/WOPTO huggingface dataset:
Patent DE-68922134-D1 (DE)
Inventor: HANADA EISUKE
IPC: G10L25/93
Filed: 1989-05-19
Granted: 1995-05-18
Abstract: In coded speech communication, discrete speech samples are analyzed to generate a first signal indicating the fine pitch structure of the speech samples and a second signal indicating their spectral characteristic. The amplitudes and locations of main excitation pulses are determined from the fine pitch structure and spectral characteristic and a third signal indicating the determined pulse amplitudes and locations is generated. The difference between the speech samples and the main excitation pulses is detected and used in auxiliary excitation pulse calculation to determine gain and index values of auxiliary excitation pulses by retrieving stored auxiliary excitation pulses from a code book so that the retrieved auxiliary excitation pulses approximate the difference. The first, second and third coded signals and the gain and index values are transmitted through a communication channel to a distant end where a replica of the main excitation pulses is recovered from the received first and third signals and a replica of the auxiliary excitation pulses is recovered from a code book in response to the received fourth signal. These replicas are modified with the second signal to recover a replica of the original speech samples.
Patent DE-69004284-D1 (DE)
Inventor: BRESCIANI ANGELO
IPC: D06P5/00
Filed: 1990-01-23
Granted: 1993-12-09
Abstract: The preparation and use of water-soluble or water-swellable copolymers by copolymerization in water-in-oil emulsions of an olephinically unsaturated acid, a salt thereof, a multifunctional monomer, acrylonitrile and optionally a monomer with hydrophilic functional groups.
Patent DE-69012700-D1 (DE)
Inventor: FETCENKO MICHAEL A
IPC: H01M4/38
Filed: 1990-07-20
Granted: 1994-10-27
Abstract: Disclosed is a method of forming a vanadium-rich, multi-component reversible, electrochemical hydrogen storage alloy directly from a vanadium-reductant alloy without first obtaining pure vanadium. In one exemplification the vanadium-reductant alloy is a vanadium-aluminum alloy of low oxygen content, while in another exemplification the vanadium-reductant alloy is refined by electron beam evaporation, and in a third exemplification the vanadium-reductant alloy contains further reductants that reduce the oxygen content without adding impurities to the alloy. The vanadium-reductant alloy is directly used as a precursor in forming the electrochemical hydrogen storage alloy.
Patent DE-69031225-D1 (DE)
Inventor: SAMUEL JOHN
IPC: C12N15/02
Filed: 1990-04-20
Granted: 1997-09-11
Abstract: The invention is a monoclonal antibody (MAb 174H.64) which selectively recognizes antigens associated with squamous cell carcinoma and stem cell populations of stratified epithelium. In well differentiated squamous cell carcinoma tumors, the antibody preferentially binds with the peripheral proliferative compartment of the tumor. The antigens recognized by MAb 174H.64 include cytoskeletal proteins with molecular weight of approximately 48 to 50kD and 57kD. The method of use of the antibody includes diagnosis of squamous cell carcinoma tumours by immunohistology, non-invasive diagnostic imaging in vivo, treatment of squamous cell carcinoma tumours using MAb conjugates of radionuclide or cytotoxic drugs, all immunopurification of SCC antigens.
Patent DE-69107414-D1 (DE)
Inventor: MORIMOTO KIYOSHI
IPC: B65G51/04
Filed: 1991-11-13
Granted: 1995-03-23
Abstract: A transport plug (A) for pneumatically transporting solid materials in a transport pipe (4) by the use of a pressurized transport gas and a pneumatic transport method of solid materials employing the transport plug (A). The transport plug (A) comprises two bodies consisting of a front body (11) and a rear body (12) defining a material storing space (X) for storing solid materials between the two bodies (11, 12), at least one supplementary body (13) connected to the rear body (12), and flexible connecting means (14) coupling said three bodies (11, 12, 13). A supplementary material storing space (Y) is defined between the supplementary body (13) and the rear body (12). Solid materials are fed into the material storing space (X) of the transport plug (A), transported through the transport pipe (4) together with the transport plug (A), and received in a collector (8) under gravitational fall. <IMAGE>
Patent DE-69129198-D1 (DE)
Inventor: COLAROW LADISLAS
IPC: A23L27/60
Filed: 1991-12-12
Granted: 1998-05-07
Abstract: The invention concerns a heat stable oil-in-water emulsion containing between 10 and 85% oil, between 1 and 10% of egg yolk, acetic acid, salt, water and between 0.1 and 5 g exogenous soybean lysophosphatidylcholine based on 1000 g of that emulsion.
Patent DE-69217004-D1 (DE)
Inventor: HAENNINEN JOUNI
IPC: H04B17/00
Filed: 1992-06-05
Granted: 1997-03-06
Abstract: PCT No. PCT/FI92/00176 Sec. 371 Date Feb. 5, 1993 Sec. 102(e) Date Feb. 5, 1993 PCT Filed Jun. 5, 1992 PCT Pub. No. WO92/22963 PCT Pub. Date Dec. 23, 1992.The base station includes for monitoring the quality of a radio link between the base station and mobile stations, a generator (1, 2, 3) for generating a square wave signal (CK) having a monitoring signal frequency; and a filter (4) for generating a monitoring signal (CS) from the square wave signal (CK). The frequency of the monitoring signal is set by a control (12) having two modes of operation; in the first mode of operation, the control controls the generator to transmit an analog monitoring signal by maintaining the frequency of the square wave signal (CK) at a constant value throughout the duration of the monitored radio link, and in the second mode of operation, the control controls the generator (1, 2, 3) to transmit a digital monitoring signal by varying the frequency during the monitored radio link in response to changes in the logical state of the monitoring signal between a first frequency corresponding to the first logical state and a second frequency corresponding to the second logical state.
Patent DE-69219415-D1 (DE)
Inventor: URBAS DONALD J
IPC: G07C9/00
Filed: 1992-07-29
Granted: 1997-06-05
Abstract: A passive transponder comprising communication antenna means for inductively receiving a first communication signal and inductively transmitting a second communication signal in response thereto, said first and second communication signals each including data and instructions, reprogrammable memory means for storing data received by said transponder, said reprogrammable memory means having a plurality of memory addresses; information generating means for creating said second communication signal in response to said first communication signal, said information generating means including memory interface means for selectively addressing an address of said reprogrammable memory in response to said first communication signal and operating on said selectively addressed memory address in response to said first communication signal.
Patent DE-69221730-D1 (DE)
Inventor: SUMMERTON JAMES
IPC: C12Q1/68
Filed: 1992-06-18
Granted: 1997-09-25
Abstract: A polymer composition effective to bind in a sequence-specific manner to a target sequence of a duplex polynucleotide containing different Watson-Crick basepair oreientaions. The composition includes an uncharged backbone with 5- or 6-membered cyclic backbone structures and selected bases attached to the backbone structures effective to hydrogen bond specifically with different oriented basepairs in the target sequence.
Patent DE-69228116-D1 (DE)
Inventor: LINDQUIST SUSAN
IPC: C12N1/18
Filed: 1992-06-03
Granted: 1999-02-18
Abstract: This invention relates to the identification, isolation, purification and manipulation of genetic stress response systems, and more particularly, to genes and expression products of those genes that are components of those systems. These components may be used to protect against potentially toxic stress factors. Stress factors include heat, alcohol and heavy metal ions. A family of stress protector proteins with apparent molecular weights about 100 kd, the hsp100 proteins, are an aspect of this invention. Other stress protector proteins are also within the scope of this invention to enhance or inhibit biological stress response. Applications of this invention to recombinant DNA technology, to commercial methods of food preparation and processing, and to methods of enhancing the stress response of plants and animals, are presented.
Patent DE-69233653-D1 (DE)
Inventor: FREYSSINET GEORGES
IPC: A01N63/50
Filed: 1992-03-04
Granted: 2006-10-12
Abstract: A DNA sequence coding for an oxalate oxidase. The protein is useful in making plants resistant to diseases caused by Sclerotinia sp. It may be provided by a chimeric gene and a vector containing the coding sequence. It is useful in increasing the resistance of plants to diseases due to Sclerotinia sp.
Patent DE-69233654-D1 (DE)
Inventor: MAGNANI L
IPC: C07K14/705
Filed: 1992-04-17
Granted: 2006-10-19
Abstract: Novel methods and compositions are provided for modulating homing of leukocytes, particularly lymphocytes, where the compounds are cross-reactive with or contain Neu5Ac2-3Gal beta 1-x[Fuc alpha 1-y]GlcNAc, where one of x and y is 3 and the other is 4. These compounds may be administered to a host associated with inflammation, to avoid the deleterious effects of leukocyte infiltration and for directing molecules to such sites. In addition, methods and compositions are disclosed for the inhibition of cancer metastases mediated by endothelial adhesion molecules. The present invention discloses that sialyl-Le<a> and di-sialyl-Le<a>, which are expressed at the surface of cancer cells, function as a binding partner for selectins, such as ELAM-1, which are expressed at the surface of endothelial cells. The present invention also discloses that selectins, such as ELAM-1, LECAM-1 and GMP-140, bind a carbohydrate domain common to both sialyl-Le<a> and sialyl-Le<x>. Antibodies, saccharides, glycoconjugates, enzymes, enzyme inhibitors and other molecules may be used in the methods of the present invention to inhibit the binding of malignant cells to endothelial cells for a variety of purposes in vivo and in vitro.
Patent DE-69304042-D1 (DE)
Inventor: BUCKLEY DANIEL T
IPC: B29K105/08
Filed: 1993-03-01
Granted: 1996-09-19
Abstract: A rigid three-dimensional preform is made by moving a plurality of webs of fibrous reinforcement material superposed and coplanar to a cutter, the webs being coated with an electromagnetic energy-curable binder and pressed together. Prior to cutting a blank in a two-dimensional development of the three-dimensional preform from the webs, the webs are tacked together at spaced local zones by locally curing the binder at those zones by locally applying the appropriate electromagnetic radiation (microwave, ultraviolet, electron) so that the webs travel as one to the cutter. After cutting of the blank, the blank is loaded into a mold to replicate the three-dimensional shape of the preform and the remainder of the binder is cured in the mold by the application of the appropriate electromagnetic radiation. An auxiliary member may be attached to the preform by applying an electromagnetic energy-curable binder to at least one location on the preform, moving the auxiliary member into a desired position and intimate contact with the binder-coated location and the binder cured at that location by the application of the appropriate electromagnetic radiation. <IMAGE>
Patent DE-69311458-D1 (DE)
Inventor: DOUHI ABDERRAHIM
IPC: C08G69/48
Filed: 1993-07-20
Granted: 1997-07-17
Abstract: Polymers and copolymers containing at least one repeat unit of formula: <IMAGE>  in which:     - R is a single bond or a hydrocarbon chain,   - R' is a hydrocarbon chain containing two or three carbon atoms,   - P is the residue of an oligomer <IMAGE> whose solution viscosity, determined in meta-cresol at 30 DEG C and at a concentration of 0.5 g/dl, is lower than 0.50 dl g<-1>.   Process for obtaining these polymers and copolymers.
Patent DE-69312091-D1 (DE)
Inventor: WARD TERENCE
IPC: C07D213/36
Filed: 1993-12-24
Granted: 1997-08-14
Abstract: PCT No. PCT/GB93/02661 Sec. 371 Date May 24, 1995 Sec. 102(e) Date May 24, 1995 PCT Filed Dec. 24, 1993 PCT Pub. No. WO94/15928 PCT Pub. Date Jul. 21, 1994Piperazine derivatives of formula (I) and their pharmaceutically acceptable salts are 5-HT1A binding agents and may be used, for example, as anxiolytics. In the formula, R and R3 are hydrogen or lower alkyl or R3 is spirocycloalkyl, R1 and R2 are aryl or heteroaryl radicals and n is 1 or 2 and m is 1 to 3 and the total of n+m is 2-4.    <IMAGE>  (I)
Patent DE-69312389-D1 (DE)
Inventor: SCHEFFER TERRY J
IPC: G09G3/36
Filed: 1993-05-12
Granted: 1997-09-04
Abstract: Method and apparatus for providing gray level addressing for passive liquid crystal display (LCD) panels having overlapping row and column electrodes defining pixels are disclosed. Depending upon whether the rows are being addressed by "standard" or "Swift" addressing, the signals for applying to the column electrodes are determined by different calculations, in all of which modes the amplitudes of the column signals are related to the gray level desired to be displayed by the individual pixels. For a split interval system, column signals of appropriate amplitude and polarity are applied during different subintervals of a characteristic time interval of the display panel depending upon the method of addressing the rows. In the full interval mode, the column signals applied over a full time interval are based on the desired gray level of all the pixels in the column, adjusted to provide the proper rms voltage across all the pixels so that they display the desired gray levels. <IMAGE>
Patent DE-69313572-D1 (DE)
Inventor: ANDERSON PAUL CATES
IPC: A61K31/4015
Filed: 1993-09-23
Granted: 1997-10-09
Abstract: Disclosed herein are compounds of the formula:    A-N(R<1>)C(O)CH2CHR<2>C(O)-B   wherein A is an oxygen-bearing radical selected from the group consisting of: (a) HO-CH(R<3>)CH2 wherein R<3> is, for example, hydrogen, lower alkyl, lower cycloalkyl, phenyl or an unsubstituted five- or six-membered heterocyclic ring containing one or two heteroatoms selected from the group of N, O or S; (b) HO-CH2CH(R<4>) wherein R<4> is, for example, lower alkyl or phenyl(lower)alkyl; and (c) HO-CR<5>(R<6>)CH2 wherein each of R<5> and R<6> is lower alkyl; or R<5> and R<6> together with the carbon atom to which they are attached form a 1,1-(lower cycloalkanediyl), 1,1-(4-hydroxycyclohexanediyl) or 1,1-(4-oxocyclohexanediyl); (d) (lower alkoxy)CR<5A)<R<6A>)CH2 wherein each of R<5A> and R<6A> is lower alkyl; or R<5A> and R<6A> together with the carbon atom to which they are attached form a 1,1-(lower cycloalkanediyl); and (e) (lower alkyl)C(O)CH2; R<1> is, for example, benzyl, alkyl, a substituted alkyl such as cyclohexylmethyl, or R<7>R<8>NC(O)CH2 wherein R<7> and R<8> are alkyl such as methyl or ethyl; R<2> is, for example, alkyl, cycloalkylmethyl, 1H-imidazol-4-ylmethyl, 4-thiazolylmethyl or (2-amino-4-thiazolyl)methyl; and B is a renin substrate transition state mimic, for example, [1(S)-(cyclohexylmethyl)-2(R),3(S)-dihydroxy-5-methylhexyl]amino. The compounds inhibit renin activity and are indicated for the treatment of hypertension and congestive heart failure.
Patent DE-69314275-D1 (DE)
Inventor: COASSIN GIOVANNI
IPC: B21B45/08
Filed: 1993-07-08
Granted: 1997-11-06
Abstract: Descaling device employing water to descale blooms, thin slabs, billets, etc., which cooperates with a mould and the zone immediately downstream therefrom, or with an induction furnace or rolling mill stands, the slabs or blooms (11;24) being fed in cooperation with the descaling device at a speed of feed of the order of 1.5-20 metres per minute, but advantageously between 4 and 10 metres per minute, the device consisting of at least one movable arm (12;13) bearing nozzle means (14) delivering descaling water, the movable arm (12;13) being associated with the face of the slab or bloom (11;24) to be descaled and having a working phase, in which the descaling water acts on the surface of the slab or bloom (11;24), and a shut-off phase, in which the descaling water does not act on the surface of the slab or bloom (11;24).
Patent DE-69316209-D1 (DE)
Inventor: ZANGER FRANK
IPC: G01L9/14
Filed: 1993-05-27
Granted: 1998-02-12
Abstract: A pressure measurement system includes a diaphragm and a chamber for exposing one side of the diaphragm to a fluid. A force transducer is provided for measuring force exerted by the fluid on the one side of the diaphragm independent of diaphragm position. A ferromagnetic plate is attached to the diaphragm to enable removable coupling of the diaphragm with a magnet permanently attached to the force transducer.
Patent DE-69318166-D1 (DE)
Inventor: KUBERASAMPATH THANGAVEL
IPC: A23L1/305
Filed: 1993-07-29
Granted: 1998-05-28
Abstract: Disclosed are methods and compositions useful in dietary applications and capable of enhancing tissue morphogenesis, including tissue development and viability in a mammal, particularly a human. The methods and compositions include a morphogen which, when provided to an individual as a food formulation or supplement, is capable of enhancing tissue development and viability in the individual.
Patent DE-69322848-D1 (DE)
Inventor: MONTOLI VINCENZO
IPC: B28D1/22
Filed: 1993-08-25
Granted: 1999-02-11
Abstract: The end device comprises: a tool carrier (30), an operative station (11), a gauge (5) to maximize the distance from the contour line of the tile (0) to the pressure points, as well as the distance from the small roller (34) or fulcrum (f) to the push-operable scoring and cutting disc-like tool (3) or scoring weight arm which is of about 30 mm. Such fulcrum (f) engaging the bottom of the guide (2), which is placed parallel over base (1) 45 mm beyond the reaction apex (7)), The power arm of the lever is 36 cm long. At parity of power arm, the weight arm is mm 90 long, whereby the pressers (4, 4') may operate at 100 mm far from the upright (10) or at least 22 mm from the contour line (0') and 32 mm inside the corner (0''). An adjuster means (38) limits the excursion of the pressers (4, 4') avoiding that the exceeding excursion thereof operates again accidentally on any of the already cut sections of the tile.
Patent DE-69324217-D1 (DE)
Inventor: FRASER DAVID
IPC: C07D213/74
Filed: 1993-12-06
Granted: 1999-05-06
Abstract: Complex of general formula I <IMAGE> in which R1, R2 and R3, which may be identical or different, represent separately a linear or branched alkyl radical of 1 to 5 carbon atoms, or, together with the nitrogen atom to which they are attached, a heterocyclic radical having 5 to 7 carbon atoms; "alk" represents a linear or branched alkylene radical having 1 to 5 carbon atoms; R4 to R8, which may be identical or different, represent hydrogen, a hydroxyl, alkoxy or aryloxy group, a primary, secondary or tertiary amino group, or the group -alk-N<+)<R1R2R3) in which "alk", R1, R2 and R 3 have the above meanings; M represents a transition metal such as Fe, Ru or Os; X represents an anion and n represents an integer corresponding to the number of positive charges of the complex.
Patent DE-69327034-D1 (DE)
Inventor: MEHTA NISHANETH K
IPC: C23G1/24
Filed: 1993-03-17
Granted: 1999-12-23
Abstract: An improved process for the decontamination of process equipment and vessels is described wherein an extractant material for the contaminant and a surfactant are vaporized, heated with steam, to condense on the internal surfaces of the vessel to trap contaminants, such as benzene, for removal from the vessel to allow safe entry for humans for inspection and maintenance.
Patent DE-69331387-D1 (DE)
Inventor: BERDE CHARLES B
IPC: A61K9/52
Filed: 1993-09-10
Granted: 2002-01-31
Abstract: An improved biodegradable controlled release system consisting of a polymeric matrix incorporating a local anesthetic for the prolonged administration of the local anesthetic agent, and a method for the manufacture thereof, are disclosed. The polymers and method of manufacture used to form the PLAMs are selected on the basis of their degradation profiles: release of the topical anesthetic in a linear, controlled manner over a period of preferably two weeks and degradation in vivo with a half-life of less than six months, more preferably two weeks, to avoid localized inflammation. Alternatively, a non-inflammatory can be incorporated into the polymer with the local anesthetic to prevent inflammation. <IMAGE>   <IMAGE>
Patent DE-69404856-D1 (DE)
Inventor: COHEN AHARON S
IPC: C12Q1/68
Filed: 1994-11-15
Granted: 1997-09-11
Abstract: Disclosed is a method for detecting and quantitating oligonucleotides with charged internucleotide linkages in biological fluids. In this method, a biological fluid sample is contacted with an anion exchange resin at from 40 DEG  C. to 65 DEG  C. for a time sufficient to enable oligonucleotides in the sample to adsorb to the resin. The absorbed oligonucleotides are then desorbed with a buffer having a salt concentration of about 1 M to 2.5 M and a pH in the range of about 6.5 to 7.5, the desorption being performed at about 40 DEG -65 DEG  C. The oligonucleotides so released are then detected and quantitated.
Patent DE-69406763-D1 (DE)
Inventor: KAGAWA TAKASHI
IPC: C07D237/22
Filed: 1994-12-15
Granted: 1997-12-18
Abstract: Pyridazinone derivatives of formula (I): <CHEM> wherein R<1> represents a hydrogen atom or a methyl group which may be substituted with an aliphatic cyclic amino group optionally containing a hetero atom in the ring thereof; each of X<1> and X<2> independently represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a cyano group, a nitro group or a group shown by - CO-NR<2>R<3> (wherein each of R<2> and R<3> independently represents an alkyl group having 1 to 6 carbon atoms); Y represents a halogen atom; Z represents an alkoxy group having 1 to 6 carbon atoms;  l represents 0 or an integer of 1 to 3; A represents CH or N; m represents 0 or an integer of 1 or 2; and n represents an integer of 1 to 8, exhibit a platelet aggregation inhibiting activity and are useful for the treatment of circulatory disorders such as cerebral infarction.
Patent DE-69409516-D1 (DE)
Inventor: HAJKO PAVICA
IPC: C12N9/00
Filed: 1994-06-08
Granted: 1998-05-14
Abstract: PCT No. PCT/SI94/00010 Sec. 371 Date Jun. 17, 1996 Sec. 102(e) Date Jun. 17, 1996 PCT Filed Jun. 8, 1994 PCT Pub. No. WO94/29292 PCT Pub. Date Dec. 22, 1994There is disclosed a process for the isolation of the hypolipaemic active substance lovastatin from a sample, e.g. fermentation broth, mycelium or filtrate of Aspergillus terreus (ATCC 20542) or Aspergillus oryzae (ATCC 74135) by extraction with butyl acetate. Simultaneously with the concentration of the extract, lactonisation takes place. There follows a direct crystallization of lovastatin in the lactone form from butyl acetate.